Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Queensland Health
Harvard Business School
Express Scripts
QuintilesIMS
Cipla
Johnson and Johnson
McKesson

Generated: December 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022114

« Back to Dashboard

NDA 022114 describes ZINGO, which is a drug marketed by Powder Pharms and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the ZINGO profile page.

The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 022114
Tradename:ZINGO
Applicant:Powder Pharms
Ingredient:lidocaine hydrochloride
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022114
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 022114
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114 NDA Powder Pharmaceuticals Inc. 61388-001 61388-001-48 12 POUCH in 1 CARTON (61388-001-48) > 1 POWDER in 1 POUCH
ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114 NDA 7T Pharma LLC 70645-123 70645-123-26 12 POWDER in 1 POUCH (70645-123-26)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYSTEM;INTRADERMALStrength0.5MG
Approval Date:Aug 16, 2007TE:RLD:No
Patent:➤ Sign UpPatent Expiration:Oct 22, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
Patent:➤ Sign UpPatent Expiration:Apr 27, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION
Patent:➤ Sign UpPatent Expiration:Sep 28, 2035Product Flag?Substance Flag?Delist Request?
Patented Use:ZINGO IS A POWDER INTRADERMAL SYSTEM THAT IS CAPABLE OF DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL ANESTHETIC ACTION

Expired US Patents for NDA 022114

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Sign Up ➤ Sign Up
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Sign Up ➤ Sign Up
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Sign Up ➤ Sign Up
Powder Pharms ZINGO lidocaine hydrochloride SYSTEM;INTRADERMAL 022114-001 Aug 16, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Merck
Julphar
Johnson and Johnson
McKinsey
Federal Trade Commission
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.